Pharmacokinetics and modeling of quercetin and metabolites.
about
Production and characterization of a spray-dried hydroxypropyl-beta-cyclodextrin/quercetin complex.Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine.3,4-Dihydroxyphenylacetic acid, a microbiota-derived metabolite of quercetin, attenuates acetaminophen (APAP)-induced liver injury through activation of Nrf-2.Systemic Absorption of Catechins after Intraruminal or Intraduodenal Application of a Green Tea Extract in CowsEffects of dietary quercetin on female fertility in mice: implication of transglutaminase 2.Improving metabolic stability of cancer chemoprotective polyphenols.Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in ratsThe influence of postharvest processing and storage of foodstuffs on the bioavailability of flavonoids and phenolic acids.Development of an IgY Antibody-Based Immunoassay for the Screening of the CYP2E1 Inhibitor/Enhancer from Herbal Medicines.Quercetin: A Treatment for Hypertension?-A Review of Efficacy and Mechanisms.Dietary inhibitors of monoamine oxidase A.In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences.The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention.Recent trends in preclinical drug-drug interaction studies of flavonoids--Review of case studies, issues and perspectives.Preparation and evaluation of folate-modified lipid nanocapsules for quercetin delivery.LC-ESI-MS/MS analysis of quercetin in rat plasma after oral administration of biodegradable nanoparticles.Protective effect of quercetin, EGCG, catechin and betaine against oxidative stress induced by ethanol in vitro.Hepatic cytochrome P-450 reductase-null mice show reduced transcriptional response to quercetin and reveal physiological homeostasis between jejunum and liver.Oral bioavailability of quercetin from different quercetin glycosides in dogs.Dose-dependent induction of signaling pathways by the flavonoid quercetin in human primary hepatocytes: A transcriptomic study.4-Hydroxyphenylacetic Acid Prevents Acute APAP-Induced Liver Injury by Increasing Phase II and Antioxidant Enzymes in Mice.Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau AggregationQuercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate
P2860
Q33465236-7DB9E610-769F-4CAB-8B82-C82922C2EC66Q35891152-6BE15241-3F5D-4F70-9A2F-B1B8092F7646Q35941776-A76E6E33-BA30-482F-87A2-EBF5F135A3CBQ36079861-0D7C9F26-184F-4048-BCFF-0D24AD4285B3Q36693338-1683CD22-D7CC-4BF0-A160-DC10B790E465Q36835817-478E8A07-8B0B-41A0-87A3-D00D2C7F6B99Q37297477-BF23360C-63F5-4293-A4FB-0F7889A225C8Q37335364-099F61EE-BB01-4960-AC13-A49190D84F16Q37525547-9372B000-5D67-445B-90AE-A32EC2C568F5Q37709452-5F0DD02B-DBAE-472D-8633-24DB9F5A423BQ37824443-E7EB899E-83F9-4D6C-83D4-1C6CA22536E4Q37920916-10623E88-E956-4386-85F7-132BE52E28B9Q38030975-DC7BC840-EBA4-43D7-9EC7-CEBC7CE7842AQ38581733-6C7C7075-6C52-4439-A524-67A94E9BA831Q39085326-29F15AB7-D153-46D5-A205-0E00A3D356F8Q40940792-3AA15E4A-9F33-45F5-84DC-042B441537A8Q42075991-2B16D35C-B5BB-4C6B-9C5A-78A3B643363FQ42679593-A96955A7-C15E-4A65-B67D-B8DD0093F5A2Q43129212-EF48A512-FD8A-49AA-96D1-444AA48C956EQ52868555-ABD53441-8BC6-468A-BEBA-C508163CEE44Q55411083-EC1DFFB2-8999-45E8-9713-E78EA07BA6B2Q58122620-9AF81892-BB32-4C85-B751-C3A07C873F97Q58200114-C520D613-9893-4BAD-813F-F2E9DE074FE8
P2860
Pharmacokinetics and modeling of quercetin and metabolites.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Pharmacokinetics and modeling of quercetin and metabolites.
@en
Pharmacokinetics and modeling of quercetin and metabolites.
@nl
type
label
Pharmacokinetics and modeling of quercetin and metabolites.
@en
Pharmacokinetics and modeling of quercetin and metabolites.
@nl
prefLabel
Pharmacokinetics and modeling of quercetin and metabolites.
@en
Pharmacokinetics and modeling of quercetin and metabolites.
@nl
P2093
P1476
Pharmacokinetics and modeling of quercetin and metabolites.
@en
P2093
Moses S S Chow
Ophelia Q P Yin
P2860
P304
P356
10.1007/S11095-005-4584-1
P577
2005-06-08T00:00:00Z